Celera Diagnostics compares genotype and/or gene expression profiles in samples from healthy and affected individuals to associate genetic and genomic markers with disease. To cost-effectively complete genome-wide scans, Celera Diagnostics operates an industrial-scale facility and utilizes proprietary data and know-how, including novel functional SNPs discovered by the Applera Genomics Initiative. Functional SNPs are those most likely to affect the function, amount or stability of proteins. Celera Diagnostics is currently conducting large-scale disease association studies for multiple common, complex diseases, including four forms of cardiovascular disease, breast cancer, rheumatoid arthritis, psoriasis, Alzheimer's disease, and liver
Please check Celera Genomics Group for more information.